Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider and approve 1. The audited Standalone ....
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova has informed BSE that its Board of Directors will meet on Friday, May 16, 2025. The meeting will consider and approve the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025. The Board will also consider recommending a Final Dividend, if any, for the financial year ended March 31, 2025. This is a standard advance intimation filed under SEBI Listing Regulations and no financial numbers have been disclosed yet.
This is a routine pre-results announcement with no immediate impact on the stock. Investors should watch for the actual Q4 and FY25 results along with the dividend decision on May 16, 2025.